Skip to main content
    U

    U.S. Physical Therapy, Inc. (USPH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $99.58
    -0.02 (-0.02%)

    Market Cap: $1.49B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    U.S. Physical Therapy, Inc. (USPH) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    U.S. Physical Therapy reported revenue of $780.99M for the fiscal year ended Dec 31, 2025, up 16.3% from the year before. That year, net income was $58.01M with a net margin of 7.4%, operating cash flow was $75.06M and free cash flow was $60.99M. The quarter ended Sep 30, 2026 had revenue of $222.56M and net income of $17.59M.

    Revenue and Margins

    The operating margin was 11.1% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $364.25M, a compound annual rate of 8.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$780.99M+16.3%39.9%11.1%7.4%
    Dec 2024$671.35M+11.0%39.5%9.4%6.8%
    Dec 2023$604.80M+9.3%40.5%8.4%6.2%
    Dec 2022$553.14M+11.7%41.3%10.3%7.8%
    Dec 2021$495.02M+17.0%42.7%14.3%11.7%
    Dec 2020$422.97M-12.2%43.2%12.4%12.4%
    Dec 2019$481.97M+6.2%42.1%14.0%11.9%
    Dec 2018$453.91M+3.4%22.4%13.3%10.8%
    Dec 2017$438.88M+20.5%45.1%12.5%6.3%
    Dec 2016$364.25MN/A44.4%13.6%7.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 27.2% from the year before. In the quarter ended Sep 2026, net income fell 0.3% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$780.99M$671.35M$604.80M$553.14M$495.02M$422.97M$481.97M$453.91M$438.88M$364.25M
    Cost of revenue$469.54M$406.31M$359.56M$324.74M$283.77M$240.25M$279.09M$263.83M$240.74M$202.53M
    Gross profit$311.45M$265.04M$245.24M$228.41M$211.25M$182.72M$202.88M$101.66M$198.14M$161.72M
    Operating income$86.68M$62.99M$50.51M$56.80M$70.65M$52.41M$67.42M$60.31M$54.73M$49.53M
    Net income$58.01M$45.60M$37.22M$43.41M$57.92M$52.49M$57.26M$48.84M$27.72M$26.27M
    EBITDA$108.50M$82.37M$70.06M$75.22M$85.67M$76.45M$77.52M$68.03M$64.44M$58.31M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$222.56M$214.06M$198.29M$202.73M$197.13M$197.34M$183.79M$180.45M$168.03M$167.19M$155.68M$154.80M
    Gross profit$90.23M$86.53M$76.79M$80.76M$78.44M$81.56M$70.69M$69.11M$66.48M$69.14M$60.32M$62.60M
    Operating income$25.10M$21.95M$12.48M$16.77M$25.33M$24.94M$19.64M$19.65M$12.85M$15.57M$14.93M-$2.43M
    Net income$17.59M$14.90M$8.16M$9.18M$17.64M$17.72M$13.47M$12.49M$9.78M$11.71M$11.62M-$1.29M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $162.46M exceeded cash and equivalents by $126.89M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.20B$1.17B$997.24M$858.15M$749.43M$594.36M$560.85M$443.17M$418.98M$351.23M
    Current assets$139.99M$137.58M$233.38M$111.27M$95.17M$87.64M$85.39M$79.21M$77.08M$65.96M
    Cash and equivalents$35.57M$41.36M$152.82M$31.59M$28.57M$32.92M$23.55M$23.37M$21.93M$20.05M
    Total liabilities$433.81M$408.42M$345.00M$373.59M$296.98M$184.39M$181.39M$92.35M$110.34M$162.54M
    Short-term debt$9.87M$11.00M$7.69M$7.86M$830.00K$4.90M$728.00K$1.43M$4.04M$1.23M
    Long-term debt$152.59M$142.53M$138.99M$175.83M$117.59M$16.60M$50.36M$38.40M$56.73M$50.60M
    Shareholder equity$476.43M$488.93M$476.19M$315.79M$295.61M$276.16M$240.26M$215.94M$204.87M$187.55M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$1.30B$1.25B$1.24B$1.20B$1.20B$1.18B$1.18B$1.17B$1.03B$1.02B$1.02B$997.24M
    Total liabilities$508.36M$482.22M$459.19M$433.81M$413.83M$414.01M$420.68M$408.42M$358.47M$353.17M$345.29M$345.00M
    Cash and equivalents$38.23M$24.89M$28.44M$35.57M$31.10M$34.09M$39.18M$41.36M$116.96M$112.91M$132.29M$152.82M
    Shareholder equity$429.30M$448.66M$468.98M$476.43M$503.57M$500.75M$497.26M$488.93M$482.76M$484.57M$479.77M$476.19M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 81.3% of operating cash flow. Dividends and share repurchases together came to 85.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$75.06M$74.94M$81.98M$58.54M$76.41M$100.00M$62.45M$73.00M$56.53M$51.05M
    Capital expenditures$14.07M$9.19M$9.29M$8.25M$8.20M$7.64M$10.19M$7.19M$7.09M$8.26M
    Free cash flow$60.99M$65.75M$72.68M$50.29M$68.20M$92.36M$52.26M$65.81M$49.43M$42.79M
    Dividends paid$46.63M$41.25M$40.23M$36.67M$35.70M$22.44M$30.79M$27.31M$15.64M$14.23M
    Share repurchases$5.57M$0$0N/AN/AN/AN/A$265.00K$2.36M$1.26M
    Investing cash flow-$36.71M-$149.45M-$45.02M-$81.27M-$124.14M-$51.20M-$37.99M-$23.91M-$43.58M-$32.49M
    Financing cash flow-$44.14M-$36.95M$84.27M$25.76M$43.38M-$39.42M-$24.27M-$47.66M-$11.06M-$14.29M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$25.72M$34.37M$3.81M$24.93M$19.94M$34.86M-$4.67M$19.41M$22.12M$28.99M$4.42M$26.84M
    Capital expenditures$5.07M$5.36M$5.37M$3.93M$4.32M$3.25M$2.58M$2.49M$2.52M$2.34M$1.84M$2.22M
    Free cash flow$20.65M$29.01M-$1.56M$21.01M$15.63M$31.61M-$7.25M$16.92M$19.60M$26.66M$2.58M$24.61M
    Last 12 quarters

    Frequently Asked Questions About USPH

    What is U.S. Physical Therapy's annual revenue?

    U.S. Physical Therapy reported revenue of $780.99M for the fiscal year ended Dec 31, 2025.

    How fast is U.S. Physical Therapy's revenue growing?

    Revenue was up 16.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.2%.

    Is U.S. Physical Therapy profitable?

    Yes. U.S. Physical Therapy reported net income of $58.01M for the fiscal year ended Dec 31, 2025, with a net margin of 7.4%.

    How much free cash flow does USPH generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $75.06M minus capital expenditures of $14.07M produced free cash flow of $60.99M.

    How much debt does U.S. Physical Therapy have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $152.59M, short-term debt of $9.87M and cash and equivalents of $35.57M.